The global drug discovery platforms market is entering a high-growth phase as pharmaceutical and biotechnology companies accelerate the adoption of artificial intelligence (AI), machine learning, computational chemistry, molecular modeling, and virtual screening. Valued at USD 3.5 billion in 2025, the market is projected to reach USD 16.5 billion by 2036, expanding at a 15.2% CAGR from 2026 to...